The current orthoebolavirus outbreak in Democratic Republic of Congo (DRC) and Uganda is confirmed to be caused by the species Orthoebolavirus bundibugyoense (Bundibugyo virus),...
Cancer cells have electrically charged parts hence are influenced by electric fields. Application of alternating electric fields (TTFields) to solid tumours selectively target and...
The henipaviruses, Hendra virus (HeV) and Nipah virus (NiV) are known to cause fatal diseases in humans. In 2022, Langya henipavirus (LayV), a novel henipavirus was identified in Eastern...
Ryoncil has been approved for the treatment of steroid-refractory acute graft-versus-host disease (SR-aGVHD), a life-threatening condition that may result from blood stem cell transplantation...
A recent study has estimated disease frequency of herpes simplex virus (HSV) infections and genital ulcer disease (GUD). The estimates suggest that about 846...
On October 22, 2024, a surgical team performed the first fully robotic double lung transplant on a 57-year-old woman with chronic obstructive pulmonary disease...
Asciminib (Scemblix) has been approved for adult patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in chronic phase (CP). The accelerated approval...
On 11 October 2024, Hympavzi (marstacimab-hncq), a human monoclonal antibody targeting “tissue factor pathway inhibitor” received US FDA’s approval as a new drug for...
BNT116 and LungVax are nucleic acid lung cancer vaccine candidates – the former is based on mRNA technology similar to “COVID-19 mRNA vaccines” such...